Literature DB >> 16006558

Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif.

Francesca Zalfa1, Salvatore Adinolfi, Ilaria Napoli, Eva Kühn-Hölsken, Henning Urlaub, Tilmann Achsel, Annalisa Pastore, Claudia Bagni.   

Abstract

Fragile X mental retardation protein (FMRP), the protein responsible for the fragile X syndrome, is an RNA-binding protein involved in localization and translation of neuronal mRNAs. One of the RNAs known to interact with FMRP is the dendritic non-translatable brain cytoplasmic RNA 1 BC1 RNA that works as an adaptor molecule linking FMRP and some of its regulated mRNAs. Here, we showed that the N terminus of FMRP binds strongly and specifically to BC1 and to its potential human analog BC200. This region does not contain a motif known to specifically recognize RNA and thus constitutes a new RNA-binding motif. We further demonstrated that FMRP recognition involves the 5' stem loop of BC1 and that this is the region that exhibits complementarity to FMRP target mRNAs, raising the possibility that FMRP plays a direct role in BC1/mRNA annealing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16006558     DOI: 10.1074/jbc.M504286200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  RNA exodus to Israel: RNA controlling function in the far reaches of the neuron. Workshop on RNA control on neuronal function.

Authors:  Gary J Bassell; Jeffery L Twiss
Journal:  EMBO Rep       Date:  2006-01       Impact factor: 8.807

Review 2.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

Review 3.  The state of synapses in fragile X syndrome.

Authors:  Brad E Pfeiffer; Kimberly M Huber
Journal:  Neuroscientist       Date:  2009-03-26       Impact factor: 7.519

Review 4.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

5.  On BC1 RNA and the fragile X mental retardation protein.

Authors:  Claudia Bagni
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-15       Impact factor: 11.205

Review 6.  LncRNAs: macromolecules with big roles in neurobiology and neurological diseases.

Authors:  Ye Chen; Jun Zhou
Journal:  Metab Brain Dis       Date:  2017-02-04       Impact factor: 3.584

Review 7.  Mechanisms and consequences of subcellular RNA localization across diverse cell types.

Authors:  Krysta L Engel; Ankita Arora; Raeann Goering; Hei-Yong G Lo; J Matthew Taliaferro
Journal:  Traffic       Date:  2020-04-29       Impact factor: 6.215

8.  A study of the ultrastructure of fragile-X-related proteins.

Authors:  Ljiljana Sjekloća; Petr V Konarev; John Eccleston; Ian A Taylor; Dmitri I Svergun; Annalisa Pastore
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

Review 9.  Long noncoding RNAs in psychiatric disorders.

Authors:  Lingjun Zuo; Yunlong Tan; Zhiren Wang; Ke-Sheng Wang; Xiangyang Zhang; Xiangning Chen; Chiang-Shan R Li; Tong Wang; Xingguang Luo
Journal:  Psychiatr Genet       Date:  2016-06       Impact factor: 2.458

10.  Temporal requirements of the fragile x mental retardation protein in modulating circadian clock circuit synaptic architecture.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Neural Circuits       Date:  2009-08-20       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.